Literature DB >> 3167683

Effect of active head movements about the pitch, roll, and yaw axes on human optokinetic afternystagmus.

S H Lafortune1, D J Ireland, R M Jell.   

Abstract

Effects of active head movements about the pitch, roll, or yaw axes on horizontal optokinetic afternystagmas (OKAN) were examined in 16 subjects to test the hypothesis that otolith organ mediated activity induced by a change in head position can couple to the horizontal velocity storage in humans. Active head movements about the pitch axis, forwards or backwards, produced significant OKAN suppression. Pitch forward head movements exerted the strongest effect. Active head movements about the roll axis towards the right also produced OKAN suppression but only if the tilted position was sustained. No suppression was observed following sustained yaw. However, an unsustained yaw left movement after rightward drum rotation significantly enhanced OKAN. Sustained head movement trials did not significantly alter subsequent control trials. In contrast, unsustained movements about the pitch axis, which involve more complex interactions, exerted long-term effects on subsequent control trials. We conclude that otolith organ mediated activity arising from pitch or roll head movements couples to the horizontal velocity storage in humans, thereby suppressing ongoing OKAN. Activity arising from the horizontal canals during an unsustained yaw movement (observed mainly with yaw left), following drum rotation in a direction contralateral to the movement, may also couple to the velocity storage, resulting in increased activity instead of suppression.

Entities:  

Mesh:

Year:  1988        PMID: 3167683     DOI: 10.1139/y88-110

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  1 in total

1.  Horizontal optokinetic nystagmus in the pigeon during static tilts in the frontal plane.

Authors:  E G Zolotilina; S V Eremina; I V Orlov
Journal:  Neurosci Behav Physiol       Date:  1995 Jul-Aug
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.